Annemiek van Maldegem

Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013

H. Gelderblom, J. Bovée, Annemiek van Maldegem, 2014, Clinical Sarcoma Research.

Etoposide and carbo‐or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study

J. Blay, U. Dirksen, P. Rutkowski, 2015, Pediatric blood & cancer.

Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.

H. Gelderblom, P. Hogendoorn, J. Bovée, 2016, European journal of cancer.

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

J. Blay, U. Dirksen, L. Billingham, 2022, BMC cancer.

Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment

A. B. Hassan, H. Gelderblom, P. Hogendoorn, 2012, Clinical Sarcoma Research.

Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.

P. Rutkowski, H. Gelderblom, Shreyaskumar R Patel, 2018, The oncologist.

Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.

H. Gelderblom, P. Hogendoorn, J. Bovée, 2016, European journal of cancer.